STOCK TITAN

Doximity Inc Stock Price, News & Analysis

DOCS NYSE

Welcome to our dedicated page for Doximity news (Ticker: DOCS), a resource for investors and traders seeking the latest updates and insights on Doximity stock.

Doximity Inc (DOCS) provides a HIPAA-secure digital platform connecting U.S. healthcare professionals through secure collaboration tools and medical networking features. This news hub offers investors and medical practitioners timely updates about platform developments, regulatory compliance milestones, and strategic partnerships.

Access comprehensive coverage of DOCS' operational updates including product innovations, financial results, and industry partnerships. All content is verified through primary sources to ensure accuracy for investment research and professional decision-making.

Key focus areas include updates on telehealth integrations, physician network expansion, and security protocol enhancements. Users benefit from centralized access to DOCS' regulatory filings, leadership announcements, and technology roadmap developments.

Bookmark this page for streamlined monitoring of Doximity's progress in advancing healthcare collaboration through its cloud-based platform. Check regularly for objective reporting on developments impacting both clinical workflows and long-term corporate strategy.

Rhea-AI Summary

Doximity, Inc. (NYSE: DOCS) will report its first-quarter financial results for the period ending June 30, 2022, after market close on August 4, 2022. A conference call to discuss these results will take place at 2:00 p.m. PT (5:00 p.m. ET). Doximity, founded in 2010, is the leading digital platform for U.S. medical professionals, encompassing over 80% of physicians across various specialties. The platform offers tools for collaboration, medical news updates, career management, and virtual patient visits, aiming to enhance productivity in healthcare.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.21%
Tags
-
Rhea-AI Summary

Doximity, Inc. (NYSE: DOCS), a leading digital platform for U.S. medical professionals, announced its participation in two key investor conferences. The first is William Blair's 42nd Annual Growth Stock Conference on June 7, 2022, where Dr. Nate Gross will present at 5:40 pm ET. The second is the Goldman Sachs 43rd Annual Global Healthcare Conference on June 16, 2022, featuring CFO Anna Bryson at 11:40 am ET. Live webcasts will be available on Doximity's investor relations website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.54%
Tags
conferences
-
Rhea-AI Summary

Doximity reported Q4 revenue of $93.7 million, a 40% increase year-over-year, with a net income margin of 39%.

For fiscal year 2022, total revenue reached $343.5 million, up 66% year-over-year, with a net income margin of 45%.

The company projects Q1 revenue between $88.6 million and $89.6 million and updates fiscal 2023 guidance to $454.0 million to $458.0 million.

Doximity also announced a $70 million stock repurchase program to buy back shares over the next year.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.25%
Tags
Rhea-AI Summary

Doximity, Inc. (NYSE:DOCS) is set to report its financial results for the fourth quarter ended March 31, 2022, after market close on May 17, 2022. A conference call and webcast will take place at 2:00 p.m. PT (5:00 p.m. ET) to discuss these results. Doximity stands as the leading digital platform for U.S. medical professionals, with over 80% of U.S. physicians in its network. Its mission is to enhance physician productivity to enable better patient care.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.85%
Tags
-
Rhea-AI Summary

Doximity's recent report indicates that over 73% of patients intend to continue using telemedicine post-pandemic. A survey of 2,000 patients found varied adoption rates among demographics, with 67% of patients adopting telemedicine in 2021. The report highlights significant adoption among physicians of all ages and specialties, particularly in endocrinology and oncology. The findings suggest that telemedicine enhances trust in patient-physician relationships.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.88%
Tags
none
-
Rhea-AI Summary

Doximity (NYSE: DOCS) announced its participation in two virtual fireside chats at investor events. The first event is the SVB Leerink Virtual 11th Annual Global Healthcare Conference on February 16, 2022, where CFO Anna Bryson will present at 1:40 pm ET. The second event is the Morgan Stanley Technology, Media & Telecom Conference 2022 on March 10, 2022, featuring co-founder and CEO Jeff Tangney at 4:50 pm ET. Webcast links for both presentations will be available on Doximity's investor relations website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.56%
Tags
conferences
Rhea-AI Summary

Doximity (NYSE: DOCS) announced the acquisition of Amion, a top on-call physician scheduling platform, managing nearly 200,000 physician schedules across thousands of hospitals. This strategic move aims to enhance Doximity's physician cloud platform by integrating scheduling capabilities, which will drive engagement across its services. The acquisition is expected to be finalized on April 1, 2022, bridging a decade-long partnership between the two companies. Amion, recognized for its efficiency in scheduling, will leverage Doximity's growth potential to provide improved tools for physicians.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
24.03%
Tags
-
Rhea-AI Summary

Doximity, Inc. (DOCS) reported a strong fiscal Q3 with revenue of $97.9 million, up 67% year-over-year. The company achieved a net income of $55.6 million with a net income margin of 57%. Key performance metrics included a 171% net revenue retention rate and an adjusted EBITDA of $47.0 million, growing 119% year-over-year. Doximity announced plans to acquire Amion, enhancing its offerings. Future guidance includes Q4 revenue between $89 million and $90 million, and for FY 2023, anticipated revenue growth of 33% to around $450 million.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
24.03%
Tags
-
Rhea-AI Summary

Doximity, Inc. (NYSE: DOCS) announced that its Doximity Dialer has been recognized as the 2022 'Best in KLAS' in the Telehealth - Video Conferencing Platforms segment. This acknowledgment highlights Dialer's high ratings in culture, loyalty, operations, product, relationship, and value, where it received 'A' grades across the board. Doximity’s HIPAA-compliant platform facilitates one-click virtual visits and is widely adopted by over 150 hospitals, enhancing patient care and connection rates.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.64%
Tags
none
Rhea-AI Summary

Doximity, Inc. (NYSE:DOCS) will report its financial results for Q3 2022, ending December 31, 2021, after market close on February 8, 2022. A conference call will follow at 2:00 p.m. PT (5:00 p.m. ET) to discuss these results. Renowned for being the leading digital platform for U.S. medical professionals, Doximity boasts over 80% of U.S. physicians in its network, providing tools for collaboration, updates on medical news, and virtual patient visits. The call will be accessible via the Company’s Investor Relations page.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.14%
Tags

FAQ

What is the current stock price of Doximity (DOCS)?

The current stock price of Doximity (DOCS) is $58.55 as of August 7, 2025.

What is the market cap of Doximity (DOCS)?

The market cap of Doximity (DOCS) is approximately 10.9B.
Doximity Inc

NYSE:DOCS

DOCS Rankings

DOCS Stock Data

10.86B
133.36M
2.29%
96.76%
2.65%
Health Information Services
Services-computer Programming Services
Link
United States
SAN FRANCISCO